All Episodes
Displaying 121 - 131 of 131 in total
22-52 Edward Humes, Pulitzer Prize Winner, "The Forever Witness"
In a long-form feature from Tech Nation, it’s Pulitzer Prize-winning author, Edward Humes, with “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double ...
22-51 Keven Ali, CEO, Organon
A new global company with 64 products, many of which are for women? Kevin Ali is the CEO of Organon.
22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR Therapeutics
Cancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO,...
22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTx
Like the idea of replacing some of your DNA with DNA that works better? And what if you want that new DNA to stop? Dr. Alexandria Forbes, the President & CEO of MeiraG...
22-48 Dr. Robert Ang, President & CEO, Vor Biopharma
Vor Biopharma has a unique approach to a particular kind of cancer – Acute Myeloid Leukemia – perhaps better known to you, as AML. Dr. Robert Ang is Vor's President & ...
22-47 Dr. James Mackay, President & CEO, Aristea Therapeutics
Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's c...
22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis Bio
Alzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they...
22-16 Triple-Negative Breast Cancer is the most aggressive of all
Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has...
Dr. George Yancopoulos, CEO, Regeneron
Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid tre...
Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics
Blood clots of any sort are dangerous. So dangerous in fact, that 1 in 4 people die from blood clots - independent of medical condition, medicines they take, or medica...
Mark Litton, President & CEO, Athira Pharma
Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natura...